RxDoctor Payments Data

Jennifer Hamilton

Nurse Practitioner · Charlotte, NCNPI 1356004840

Payments from drug & device makers

$633in general payments, 2019–2025

Across 38 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$126
  • Novo Nordisk$92
  • AstraZeneca$82
  • Abbott$47
  • GSK$41
  • Lilly USA, LLC$41
  • plus $203 from 9 others

What the payments were for

  • Food & beverage$633100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$633 in reported general payments places this provider in the 70th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$19,720
Medicare patients
74
Services billed
364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin55$56,980
TrulicityDulaglutide35$33,529
EliquisApixaban27$28,028
SymbicortBudesonide/Formoterol Fumarate41$12,073
OzempicSemaglutide13$11,977
XareltoRivaroxaban21$11,171
Breo ElliptaFluticasone/Vilanterol17$8,185
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$8,169
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,387
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,862
Albuterol Sulfate HfaAlbuterol Sulfate75$1,682
SynthroidLevothyroxine Sodium14$1,374
Gabapentin77$1,026
Omeprazole69$924
Ziprasidone Hcl21$908

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$126$56,98055 claims
Lilly USA, LLCTrulicity$41$33,52935 claims
PfizerEliquis$16$28,02827 claims
GSKBreo Ellipta, Anoro Ellipta$41$13,57228 claims
AstraZenecaSymbicort$82$12,07341 claims
Novo NordiskOzempic$92$11,97713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →